Table of Content

1 HIV Medicines Market Overview
1.1 Product Overview and Scope of HIV Medicines
1.2 HIV Medicines Segment by Type
1.2.1 Global HIV Medicines Market Value Comparison by Type (2024-2034)
1.2.2 2 Medicines/Pill
1.2.3 3 Medicines/Pill
1.2.4 4 Medicines/Pill
1.3 HIV Medicines Segment by Application
1.3.1 Global HIV Medicines Market Value by Application: (2024-2034)
1.3.2 Male
1.3.3 Female
1.4 Global HIV Medicines Market Size Estimates and Forecasts
1.4.1 Global HIV Medicines Revenue 2024-2034
1.4.2 Global HIV Medicines Sales 2024-2034
1.4.3 Global HIV Medicines Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 HIV Medicines Market Competition by Manufacturers
2.1 Global HIV Medicines Sales Market Share by Manufacturers (2024-2024)
2.2 Global HIV Medicines Revenue Market Share by Manufacturers (2024-2024)
2.3 Global HIV Medicines Average Price by Manufacturers (2024-2024)
2.4 Global HIV Medicines Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of HIV Medicines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HIV Medicines, Product Type & Application
2.7 HIV Medicines Market Competitive Situation and Trends
2.7.1 HIV Medicines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest HIV Medicines Players Market Share by Revenue
2.7.3 Global HIV Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HIV Medicines Retrospective Market Scenario by Region
3.1 Global HIV Medicines Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global HIV Medicines Global HIV Medicines Sales by Region: 2024-2034
3.2.1 Global HIV Medicines Sales by Region: 2024-2024
3.2.2 Global HIV Medicines Sales by Region: 2024-2034
3.3 Global HIV Medicines Global HIV Medicines Revenue by Region: 2024-2034
3.3.1 Global HIV Medicines Revenue by Region: 2024-2024
3.3.2 Global HIV Medicines Revenue by Region: 2024-2034
3.4 North America HIV Medicines Market Facts & Figures by Country
3.4.1 North America HIV Medicines Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America HIV Medicines Sales by Country (2024-2034)
3.4.3 North America HIV Medicines Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe HIV Medicines Market Facts & Figures by Country
3.5.1 Europe HIV Medicines Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe HIV Medicines Sales by Country (2024-2034)
3.5.3 Europe HIV Medicines Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HIV Medicines Market Facts & Figures by Country
3.6.1 Asia Pacific HIV Medicines Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific HIV Medicines Sales by Country (2024-2034)
3.6.3 Asia Pacific HIV Medicines Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HIV Medicines Market Facts & Figures by Country
3.7.1 Latin America HIV Medicines Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America HIV Medicines Sales by Country (2024-2034)
3.7.3 Latin America HIV Medicines Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HIV Medicines Market Facts & Figures by Country
3.8.1 Middle East and Africa HIV Medicines Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa HIV Medicines Sales by Country (2024-2034)
3.8.3 Middle East and Africa HIV Medicines Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HIV Medicines Sales by Type (2024-2034)
4.1.1 Global HIV Medicines Sales by Type (2024-2024)
4.1.2 Global HIV Medicines Sales by Type (2024-2034)
4.1.3 Global HIV Medicines Sales Market Share by Type (2024-2034)
4.2 Global HIV Medicines Revenue by Type (2024-2034)
4.2.1 Global HIV Medicines Revenue by Type (2024-2024)
4.2.2 Global HIV Medicines Revenue by Type (2024-2034)
4.2.3 Global HIV Medicines Revenue Market Share by Type (2024-2034)
4.3 Global HIV Medicines Price by Type (2024-2034)
5 Segment by Application
5.1 Global HIV Medicines Sales by Application (2024-2034)
5.1.1 Global HIV Medicines Sales by Application (2024-2024)
5.1.2 Global HIV Medicines Sales by Application (2024-2034)
5.1.3 Global HIV Medicines Sales Market Share by Application (2024-2034)
5.2 Global HIV Medicines Revenue by Application (2024-2034)
5.2.1 Global HIV Medicines Revenue by Application (2024-2024)
5.2.2 Global HIV Medicines Revenue by Application (2024-2034)
5.2.3 Global HIV Medicines Revenue Market Share by Application (2024-2034)
5.3 Global HIV Medicines Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Corporation Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences HIV Medicines Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Gilead Sciences HIV Medicines Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 Biocon Limited
6.2.1 Biocon Limited Corporation Information
6.2.2 Biocon Limited Description and Business Overview
6.2.3 Biocon Limited HIV Medicines Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Biocon Limited HIV Medicines Product Portfolio
6.2.5 Biocon Limited Recent Developments/Updates
6.3 Flamingo Pharmaceuticals Limited
6.3.1 Flamingo Pharmaceuticals Limited Corporation Information
6.3.2 Flamingo Pharmaceuticals Limited Description and Business Overview
6.3.3 Flamingo Pharmaceuticals Limited HIV Medicines Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Flamingo Pharmaceuticals Limited HIV Medicines Product Portfolio
6.3.5 Flamingo Pharmaceuticals Limited Recent Developments/Updates
6.4 IPCA Laboratories
6.4.1 IPCA Laboratories Corporation Information
6.4.2 IPCA Laboratories Description and Business Overview
6.4.3 IPCA Laboratories HIV Medicines Sales, Revenue and Gross Margin (2024-2024)
6.4.4 IPCA Laboratories HIV Medicines Product Portfolio
6.4.5 IPCA Laboratories Recent Developments/Updates
6.5 Medisist Pharma
6.5.1 Medisist Pharma Corporation Information
6.5.2 Medisist Pharma Description and Business Overview
6.5.3 Medisist Pharma HIV Medicines Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Medisist Pharma HIV Medicines Product Portfolio
6.5.5 Medisist Pharma Recent Developments/Updates
6.6 Affine Formulations Limited
6.6.1 Affine Formulations Limited Corporation Information
6.6.2 Affine Formulations Limited Description and Business Overview
6.6.3 Affine Formulations Limited HIV Medicines Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Affine Formulations Limited HIV Medicines Product Portfolio
6.6.5 Affine Formulations Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HIV Medicines Industry Chain Analysis
7.2 HIV Medicines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HIV Medicines Production Mode & Process
7.4 HIV Medicines Sales and Marketing
7.4.1 HIV Medicines Sales Channels
7.4.2 HIV Medicines Distributors
7.5 HIV Medicines Customers
8 HIV Medicines Market Dynamics
8.1 HIV Medicines Industry Trends
8.2 HIV Medicines Market Drivers
8.3 HIV Medicines Market Challenges
8.4 HIV Medicines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global HIV Medicines Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global HIV Medicines Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global HIV Medicines Market Competitive Situation by Manufacturers in 2022
Table 4. Global HIV Medicines Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global HIV Medicines Sales Market Share by Manufacturers (2024-2024)
Table 6. Global HIV Medicines Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global HIV Medicines Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market HIV Medicines Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of HIV Medicines, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of HIV Medicines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of HIV Medicines, Product Type & Application
Table 12. Global Key Manufacturers of HIV Medicines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global HIV Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Medicines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global HIV Medicines Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global HIV Medicines Sales by Region (2024-2024) & (K Units)
Table 18. Global HIV Medicines Sales Market Share by Region (2024-2024)
Table 19. Global HIV Medicines Sales by Region (2024-2034) & (K Units)
Table 20. Global HIV Medicines Sales Market Share by Region (2024-2034)
Table 21. Global HIV Medicines Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global HIV Medicines Revenue Market Share by Region (2024-2024)
Table 23. Global HIV Medicines Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global HIV Medicines Revenue Market Share by Region (2024-2034)
Table 25. North America HIV Medicines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America HIV Medicines Sales by Country (2024-2024) & (K Units)
Table 27. North America HIV Medicines Sales by Country (2024-2034) & (K Units)
Table 28. North America HIV Medicines Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America HIV Medicines Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe HIV Medicines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe HIV Medicines Sales by Country (2024-2024) & (K Units)
Table 32. Europe HIV Medicines Sales by Country (2024-2034) & (K Units)
Table 33. Europe HIV Medicines Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe HIV Medicines Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific HIV Medicines Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific HIV Medicines Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific HIV Medicines Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific HIV Medicines Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific HIV Medicines Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America HIV Medicines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America HIV Medicines Sales by Country (2024-2024) & (K Units)
Table 42. Latin America HIV Medicines Sales by Country (2024-2034) & (K Units)
Table 43. Latin America HIV Medicines Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America HIV Medicines Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa HIV Medicines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa HIV Medicines Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa HIV Medicines Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa HIV Medicines Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa HIV Medicines Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global HIV Medicines Sales (K Units) by Type (2024-2024)
Table 51. Global HIV Medicines Sales (K Units) by Type (2024-2034)
Table 52. Global HIV Medicines Sales Market Share by Type (2024-2024)
Table 53. Global HIV Medicines Sales Market Share by Type (2024-2034)
Table 54. Global HIV Medicines Revenue (US$ Million) by Type (2024-2024)
Table 55. Global HIV Medicines Revenue (US$ Million) by Type (2024-2034)
Table 56. Global HIV Medicines Revenue Market Share by Type (2024-2024)
Table 57. Global HIV Medicines Revenue Market Share by Type (2024-2034)
Table 58. Global HIV Medicines Price (US$/Unit) by Type (2024-2024)
Table 59. Global HIV Medicines Price (US$/Unit) by Type (2024-2034)
Table 60. Global HIV Medicines Sales (K Units) by Application (2024-2024)
Table 61. Global HIV Medicines Sales (K Units) by Application (2024-2034)
Table 62. Global HIV Medicines Sales Market Share by Application (2024-2024)
Table 63. Global HIV Medicines Sales Market Share by Application (2024-2034)
Table 64. Global HIV Medicines Revenue (US$ Million) by Application (2024-2024)
Table 65. Global HIV Medicines Revenue (US$ Million) by Application (2024-2034)
Table 66. Global HIV Medicines Revenue Market Share by Application (2024-2024)
Table 67. Global HIV Medicines Revenue Market Share by Application (2024-2034)
Table 68. Global HIV Medicines Price (US$/Unit) by Application (2024-2024)
Table 69. Global HIV Medicines Price (US$/Unit) by Application (2024-2034)
Table 70. Gilead Sciences Corporation Information
Table 71. Gilead Sciences Description and Business Overview
Table 72. Gilead Sciences HIV Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Gilead Sciences HIV Medicines Product
Table 74. Gilead Sciences Recent Developments/Updates
Table 75. Biocon Limited Corporation Information
Table 76. Biocon Limited Description and Business Overview
Table 77. Biocon Limited HIV Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Biocon Limited HIV Medicines Product
Table 79. Biocon Limited Recent Developments/Updates
Table 80. Flamingo Pharmaceuticals Limited Corporation Information
Table 81. Flamingo Pharmaceuticals Limited Description and Business Overview
Table 82. Flamingo Pharmaceuticals Limited HIV Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Flamingo Pharmaceuticals Limited HIV Medicines Product
Table 84. Flamingo Pharmaceuticals Limited Recent Developments/Updates
Table 85. IPCA Laboratories Corporation Information
Table 86. IPCA Laboratories Description and Business Overview
Table 87. IPCA Laboratories HIV Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. IPCA Laboratories HIV Medicines Product
Table 89. IPCA Laboratories Recent Developments/Updates
Table 90. Medisist Pharma Corporation Information
Table 91. Medisist Pharma Description and Business Overview
Table 92. Medisist Pharma HIV Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Medisist Pharma HIV Medicines Product
Table 94. Medisist Pharma Recent Developments/Updates
Table 95. Affine Formulations Limited Corporation Information
Table 96. Affine Formulations Limited Description and Business Overview
Table 97. Affine Formulations Limited HIV Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Affine Formulations Limited HIV Medicines Product
Table 99. Affine Formulations Limited Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. HIV Medicines Distributors List
Table 103. HIV Medicines Customers List
Table 104. HIV Medicines Market Trends
Table 105. HIV Medicines Market Drivers
Table 106. HIV Medicines Market Challenges
Table 107. HIV Medicines Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of HIV Medicines
Figure 2. Global HIV Medicines Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global HIV Medicines Market Share by Type in 2022 & 2034
Figure 4. 2 Medicines/Pill Product Picture
Figure 5. 3 Medicines/Pill Product Picture
Figure 6. 4 Medicines/Pill Product Picture
Figure 7. Global HIV Medicines Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global HIV Medicines Market Share by Application in 2022 & 2034
Figure 9. Male
Figure 10. Female
Figure 11. Global HIV Medicines Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 12. Global HIV Medicines Market Size (2024-2034) & (US$ Million)
Figure 13. Global HIV Medicines Sales (2024-2034) & (K Units)
Figure 14. Global HIV Medicines Average Price (US$/Unit) & (2024-2034)
Figure 15. HIV Medicines Report Years Considered
Figure 16. HIV Medicines Sales Share by Manufacturers in 2022
Figure 17. Global HIV Medicines Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest HIV Medicines Players: Market Share by Revenue in 2022
Figure 19. HIV Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 20. Global HIV Medicines Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 21. North America HIV Medicines Sales Market Share by Country (2024-2034)
Figure 22. North America HIV Medicines Revenue Market Share by Country (2024-2034)
Figure 23. United States HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 24. Canada HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Europe HIV Medicines Sales Market Share by Country (2024-2034)
Figure 26. Europe HIV Medicines Revenue Market Share by Country (2024-2034)
Figure 27. Germany HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. France HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. U.K. HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Italy HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Russia HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Asia Pacific HIV Medicines Sales Market Share by Region (2024-2034)
Figure 33. Asia Pacific HIV Medicines Revenue Market Share by Region (2024-2034)
Figure 34. China HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Japan HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. South Korea HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. India HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Australia HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. China Taiwan HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Southeast Asia HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Latin America HIV Medicines Sales Market Share by Country (2024-2034)
Figure 42. Latin America HIV Medicines Revenue Market Share by Country (2024-2034)
Figure 43. Mexico HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Brazil HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Argentina HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Colombia HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Middle East & Africa HIV Medicines Sales Market Share by Country (2024-2034)
Figure 48. Middle East & Africa HIV Medicines Revenue Market Share by Country (2024-2034)
Figure 49. Turkey HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Saudi Arabia HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. UAE HIV Medicines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Global Sales Market Share of HIV Medicines by Type (2024-2034)
Figure 53. Global Revenue Market Share of HIV Medicines by Type (2024-2034)
Figure 54. Global HIV Medicines Price (US$/Unit) by Type (2024-2034)
Figure 55. Global Sales Market Share of HIV Medicines by Application (2024-2034)
Figure 56. Global Revenue Market Share of HIV Medicines by Application (2024-2034)
Figure 57. Global HIV Medicines Price (US$/Unit) by Application (2024-2034)
Figure 58. HIV Medicines Value Chain
Figure 59. HIV Medicines Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed